Investors – Highly Capitalized

Monday, July 20, 2026 We Follow The Money.

Ascend Wellness Seeks Shareholder Approval for Reverse Stock Split Ahead of Potential Uplisting

HCN News Team2026-07-13T06:25:10-08:00July 13th, 2026|Investors|

NEW YORK – Ascend Wellness Holdings Inc., a vertically integrated ...

High Tide Tightens Ownership Guardrails with New Two-Part Rights Plan

HCN News Team2026-07-06T08:12:03-08:00July 6th, 2026|Business, Investors|

CALGARY – High Tide Inc. announced that its board of ...

Glass House Brands Gains NYSE Listing Approval

HCN News Team2026-06-25T06:19:10-08:00June 25th, 2026|Investors|

LONG BEACH – Glass House Brands Inc. has secured approval ...

Glass House Brands Triggers Warrant Acceleration

HCN News Team2026-06-24T03:16:00-08:00June 24th, 2026|Business, Investors|

LONG BEACH – Glass House Brands Inc., a major player ...

Trulieve Announces Share Buyback Program

HCN News Team2026-06-10T02:16:16-08:00June 10th, 2026|Business, Investors|

TALLAHASSEE – Trulieve Cannabis Corp. announced that its Board of ...

Vireo Growth Initiates Share Consolidation

HCN News Team2026-06-02T04:37:36-08:00June 2nd, 2026|Business, Investors|

MINNEAPOLIS – Vireo Growth Inc. continues to adjust its capital ...

Verano Consolidates Shares Ahead of U.S. Exchange Listing

HCN News Team2026-06-01T05:02:15-08:00June 1st, 2026|Business, Investors|

CHICAGO – Verano Holdings Corp. announced that its Board of ...

Glass House Brands Wraps Up Warrant Redemption

HCN News Team2026-06-01T01:33:59-08:00June 1st, 2026|Business, Investors|

LONG BEACH – Glass House Brands Inc. confirmed that it ...

Curaleaf Announces 1-for-3 Reverse Stock Split to Clear Path for U.S. Exchange Listing

HCN News Team2026-05-27T00:02:02-08:00May 27th, 2026|Business, Investors|

STAMFORD – Curaleaf Holdings Inc. has announced a 1-for-3 reverse ...

Jazz Pharmaceuticals: The Medical Cannabis Insider Nearing $1B Milestone

HCN News Team2025-11-27T06:21:28-08:00November 27th, 2025|International, Investors|

DUBLIN – Jazz Pharmaceuticals reported a 20% jump in Q3 ...

DISCLAIMER NOTE: This email should be considered strictly private and confidential. Sender of this email is not a United States Securities Dealer, nor Broker, nor U.S. Investment Adviser. Sender is a Registered Corporation and Consultant, and makes no warranties, nor representations as to the buyer, seller, or transaction. Furthermore, this email includes forward-looking statements within the meaning of Section 27A of the Securities Act of 1933, as amended (the “Securities Act”), and Section 21E of the Securities Exchange Act of 1934, as amended (the “Exchange Act”). Read more

HCN Media Group | 171 Pier Avenue, Suite 177, Santa Monica, California, 90405

© Copyright | Highly Capitalized | All Rights Reserved | Website by Vadimages.